EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

De Novo Drug Design Using Artificial Intelligence Applied on SARS-CoV-2 Viral Proteins ASYNT-GAN

Ivan Jacobs, Manolis Maragoudakis

BioChem · 2021

DOI: 10.3390/biochem1010004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioChem, 2021. Verfasst von Ivan Jacobs und 1 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Computer-assisted de novo design of natural product mimetics offers a viable strategy to reduce synthetic efforts and obtain natural-product-inspired bioactive small molecules, but suffers from several limitations. Deep learning techniques can help address these shortcomings. We propose the generation of synthetic molecule structures that optimizes the binding affinity to a target. To achieve this, we leverage important advancements in deep learning. Our approach generalizes to systems beyond the source system and achieves the generation of complete structures that optimize the binding to a target unseen during training. Translating the input sub-systems into the latent space permits the ability to search for similar structures, and the sampling from the latent space for generation.

Zitieren

APA

Jacobs, I., & Maragoudakis, M. (2021). De Novo Drug Design Using Artificial Intelligence Applied on SARS-CoV-2 Viral Proteins ASYNT-GAN. BioChem. https://doi.org/10.3390/biochem1010004

Vancouver

Jacobs I, Maragoudakis M. De Novo Drug Design Using Artificial Intelligence Applied on SARS-CoV-2 Viral Proteins ASYNT-GAN. BioChem. 2021. doi:10.3390/biochem1010004

BibTeX
@article{Jacobs2021,
  author = {Jacobs, Ivan and Maragoudakis, Manolis},
  title = {De Novo Drug Design Using Artificial Intelligence Applied on SARS-CoV-2 Viral Proteins ASYNT-GAN},
  journal = {BioChem},
  year = {2021},
  doi = {10.3390/biochem1010004}
}
Kostenlos starten →